Early vitamin D3 supplementation for critically ill patients
Official title: Effects of Early Vitamin D3 Supplementation on Clinical Outcomes for Critically Ill Patients
Run by National Taiwan University Hospital · NCT05937789 · Data updated 2026-11-12
This study tests if giving vitamin D3 early to critically ill patients with low levels can improve their health while they are in the ICU.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 240 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | January 22, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | August 16, 2024 |
| Trial ID | NCT05937789 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are critically ill patients aged 18 and older with serum 25(OH)D levels below 20 ng/mL and expected ICU stays of at least 72 hours.
✕Probably not a fit
Patients with conditions affecting calcium metabolism, recent high-dose vitamin D therapy, or active COVID-19 will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the effects of early vitamin D3 supplementation on critically ill patients with low calcidiol levels. Conducted in Taiwan, it aims to enroll 240 patients who will receive varying doses of vitamin D to maintain serum calcidiol levels above 30 ng/mL within 30 days of ICU admission. The study measures serum calcidiol and PTH levels at multiple time points to assess the impact of supplementation on patient outcomes. The findings will help establish guidelines for vitamin D treatment in critically ill patients.
Why it matters
Potential benefit: If successful, this study could improve clinical outcomes and reduce complications for critically ill patients with vitamin D deficiency.
How similar studies have gone: Previous studies have shown that vitamin D supplementation can reduce in-hospital mortality and infection rates in severely deficient patients, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18-year-old critically ill patient. * ICU admission \< 24 hours. * Baseline 25(OH)D levels within 24 hours of ICU admission \< 20 ng/mL. * Expected ICU length of stay ≥ 72 hours. Exclusion Criteria: * Hypercalcemia (ie. total serum calcium levels \> 2.6 mmol/L). * Disorders affecting serum 25(OH)D levels, calcium metabolism, or bone metabolism (eg, parathyroid disease, rickets, or severe cirrhosis \[Child C\]). * Having received high-dose vitamin D3 therapy (ie. \> 2,000 IU daily or a single dose of ≥ 10,000 IU) within the past four weeks. * Active COVID-19 at ICU admission. * Organ transplant. * Having had tuberculosis, sarcoidosis or kidney stones within the past year. * Having renal dialysis, continuous kidney replacement therapy (CKRT), acute kidney injury (AKI). * Having ICU admission within the past three months. * Non-native-speaking patients and their families * Pregnant women.
Where it's running
-
National Taiwan University Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Yin Yi Han, doctor
- Email: noviahan@gmail.com
- Phone: 886972651405
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Vitamin D Supplementation in Children with Irritable Bowel Syndrome
This study tests whether giving vitamin D to children with IBS and low vitamin D levels can improve their IBS symptoms compared with a placebo.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.